NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

But what you're stating, repeatedly, doesn't line up AT ALL with the reasons that the UK Gov itself states the MHRA consults with the CHM for, as cited below:

That is for the first CHM meeting. The one held in June 2024.

The only statements I have ever seen on a second meeting is that they are required by law if major objections exit, and the guidance (not mandatory) says they will only be used for major objections.